Literature DB >> 31670834

Diagnosis and Management of Placental Mesenchymal Disease. A Review of the Literature.

Rachael M Colpaert1, Abigail M Ramseyer2, Thanh Luu1, Charles M Quick3, Lance T Frye4, Everett F Magann5.   

Abstract

OBJECTIVE: To review what is currently known about placental mesenchymal dysplasia (PMD) including imaging techniques for diagnosis and differentiation from a molar pregnancy, genetics, maternal/fetal effects, and management. EVIDENCE ACQUISITION: A literature search by research librarians at 2 universities was undertaken using the search engines PubMed and Web of Science. The search terms used were "etiology" OR "cause" OR "risk" OR "risks" OR "epidemiology" OR "diagnosis" OR "therapy" OR "prognosis" OR "management" AND "placental mesenchymal dysplasia" OR "placenta" AND "mesenchymal dysplasia." No limit was put on the number of years searched.
RESULTS: The etiology of PMD remains uncertain, although there are a number of theories on causation. An elevated maternal serum α-fetoprotein level, slightly elevated human chorionic gonadotropin level, normal karyotype, multicystic lesions on ultrasound, and varying degrees of flow within cysts using color Doppler (stained-glass appearance) are helpful in making the diagnosis. On pathologic examination of the placenta, PMD is differentiated from molar pregnancy by the absence of trophoblastic hyperplasia. Fetal complications of PMD include hematologic disorders, Beckwith-Wiedemann syndrome, liver tumors, fetal growth restriction, preterm delivery, and intrauterine fetal demise. Maternal complications include gestational hypertension, preeclampsia, HELLP (hemolysis, elevated liver function tests, low platelets) syndrome, and eclampsia.
CONCLUSIONS: Accurate diagnosis of PMD is imperative for appropriate management and surveillance to minimize adverse maternal and fetal outcomes. RELEVANCE: The importance of a correct diagnosis of PMD is important because it can be misdiagnosed as a partial molar pregnancy or a complete mole with coexisting normal fetus, and this can result in inappropriate management.

Entities:  

Mesh:

Year:  2019        PMID: 31670834     DOI: 10.1097/OGX.0000000000000716

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  5 in total

1.  When a vesicular placenta meets a live fetus: case report of twin pregnancy with a partial hydatidiform mole.

Authors:  Minhuan Lin; Jinzhu Chen; Bing Liao; Zhiming He; Shaobin Lin; Yanmin Luo
Journal:  BMC Pregnancy Childbirth       Date:  2021-10-13       Impact factor: 3.007

Review 2.  A Challenging Diagnosis: Placental Mesenchymal Dysplasia-Literature Review and Case Report.

Authors:  Claudia Mehedintu; Francesca Frincu; Oana-Maria Ionescu; Monica Mihaela Cirstoiu; Maria Sajin; Maria Olinca; Elvira Bratila; Aida Petca; Andreea Carp-Veliscu
Journal:  Diagnostics (Basel)       Date:  2022-01-24

Review 3.  Update on Color Flow Imaging in Obstetrics.

Authors:  Kwok-Yin Leung; Yung-Liang Wan
Journal:  Life (Basel)       Date:  2022-01-31

4.  Analysis of Effect on Infection Factors and Nursing Care of Postoperative Incision in Gynecological Cancer Patients.

Authors:  Yan Sun
Journal:  Biomed Res Int       Date:  2021-12-06       Impact factor: 3.411

5.  Variants in Maternal Effect Genes and Relaxed Imprinting Control in a Special Placental Mesenchymal Dysplasia Case with Mild Trophoblast Hyperplasia.

Authors:  Tien-Chi Huang; Kung-Chao Chang; Jen-Yun Chang; Yi-Shan Tsai; Yao-Jong Yang; Wei-Chun Chang; Chu-Fan Mo; Pei-Hsiu Yu; Chun-Ting Chiang; Shau-Ping Lin; Pao-Lin Kuo
Journal:  Biomedicines       Date:  2021-05-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.